Skip to main content
. 2018 Jan 23;5:1. doi: 10.3389/fmed.2018.00001

Figure 3.

Figure 3

Membrane hyperpolarization of purinergic agonist α,β-MeATP. Panel (A) shows actual examples and panel (B) shows cumulative data on the amplitudes of the purinergic inhibitory junction potential. Note that hyperpolarization to α,β-MeATP was no different in hyperglycemic NOD as compared to wild-type (WT) control.